- Home
- FLO vs ATAI Comparison
FLO vs ATAI Comparison
Compare FLO & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLO | ATAI |
|---|---|---|
| Founded | 1919 | 2018 |
| Country | United States | United States |
| Employees | 10300 | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2000 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FLO | ATAI |
|---|---|---|
| Price | $7.77 | $4.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | $11.20 | ★ $15.88 |
| AVG Volume (30 Days) | ★ 7.1M | 5.0M |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | ★ 11.16% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $5,256,479,000.00 | $4,089,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.65 | N/A |
| P/E Ratio | $38.65 | ★ N/A |
| Revenue Growth | 3.00 | ★ 1227.60 |
| 52 Week Low | $6.80 | $2.00 |
| 52 Week High | $16.85 | $6.73 |
Technical Indicators
Market Signals| Indicator | FLO | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 48.20 |
| Support Level | $6.80 | $4.00 |
| Resistance Level | $8.24 | $4.20 |
| Average True Range (ATR) | 0.32 | 0.33 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 67.82 | 29.20 |
Price Performance
Historical ComparisonAbout FLO Flowers Foods Inc.
Flowers Foods Inc operates as a producer and marketer of packaged bakery foods in the United States. Its principal products include breads, buns, rolls, snack items (bars, cakes, cookies, and crackers), bagels, English muffins, tortillas, and baking mixes. These products are sold under the brand names Nature's Own, Dave's Killer Bread (DKB), Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. The company derives the majority of its revenue from the sales of its bakery products.
About ATAI ATAI Life Sciences N.V.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.